Skip to main content
Signal8
Amman Bradford K. profile photo

Bradford K. Amman

CIK: 0001425339

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Vivos Therapeutics, Inc. logo
VVOS

Vivos Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Vivos Therapeutics, Inc. logo
    VVOS

    Vivos Therapeutics, Inc.

    Jul 31, 2026
    Award(A)
    Direct
    250K shares at avg. $0.41$103K
  • Vivos Therapeutics, Inc. logo
    VVOS

    Vivos Therapeutics, Inc.

    Nov 26, 2024
    Award(A)

    Stock Option (Right to Buy)

    Direct
    149.5K shares at avg. $2.64-

1-2 of 2

About Amman Bradford K.

Amman Bradford K. (SEC CIK 0001425339) files insider reports with the SEC as Principal Accounting Officer of Vivos Therapeutics, Inc. (VVOS).

Signal8 holds 2 ownership filings by Amman Bradford K., all Form 4s, filed between Nov 27, 2024 and Aug 26, 2026. Those filings report 2 transactions, from Nov 26, 2024 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Amman Bradford K.'s filings is in LITTLETON, CO.

Recent filings by Amman Bradford K.

  • Jul 31, 2026: Grant or award of VVOS shares (Form 4, code A).
  • Nov 26, 2024: Grant or award of VVOS derivative securities (Form 4, code A).

Other insiders filing for Vivos Therapeutics, Inc. (VVOS)

How to read Form 4 transaction codes